lobbying_activities: 2818237

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2818237	b955cf93-002d-4ea5-b22a-725064ae3cb8	Q2	MAGILL ASSOCIATES, LLC	401103511	THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES	2022	second_quarter	MED	H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine	Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2022-07-13T14:31:14-04:00